Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2004-05-28
2010-10-26
Seaman, D. Margaret (Department: 1625)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C549S049000, C548S152000
Reexamination Certificate
active
07820837
ABSTRACT:
The present invention aims at providing a novel fused ring compound having a GPR40 receptor function modulating action and being useful as an insulin secretagogue or a pharmaceutical agent for the prophylaxis or treatment of diabetes, more particularly, a compound represented by the formula:wherein Ar is an optionally substituted cyclic group,ring A is a ring optionally further substituted (provided that the ring is not thiazole, oxazole, imidazole and pyrazole),Xa and Xb are each independently a bond or a spacer having a main chain of 1 to 5 atom(s),Xc is O, S, SO or SO2,ring B is a 5- to 7-membered ring,Xd is a bond, CH or CH2,is a single bond when Xd is a bond or CH2, or a double bond when Xd is CH, andR1is an optionally substituted hydroxy group, and a salt thereof.
REFERENCES:
patent: 6875780 (2005-04-01), Auerbach et al.
patent: 7244763 (2007-07-01), Bratton et al.
patent: 2002/0103242 (2002-08-01), Sahoo et al.
patent: 2004/0058965 (2004-03-01), Momose et al.
patent: 1 398 313 (2004-03-01), None
patent: 1 535 915 (2005-06-01), None
patent: 1535915 (2005-06-01), None
patent: 1559422 (2005-08-01), None
patent: 2001-122817 (2001-05-01), None
patent: 98/00403 (1998-01-01), None
patent: WO 98/38156 (1998-09-01), None
patent: WO 99/11255 (1999-03-01), None
patent: WO 99/11255 (1999-03-01), None
patent: WO 00/64876 (2000-11-01), None
patent: WO 01/47859 (2001-07-01), None
patent: 01/66098 (2001-09-01), None
patent: 02/00633 (2002-01-01), None
patent: 02/26729 (2002-04-01), None
patent: WO02/053547 (2002-07-01), None
patent: WO 02/057783 (2002-07-01), None
patent: WO 02/083616 (2002-10-01), None
patent: WO 03/011842 (2003-02-01), None
patent: WO 03/074051 (2003-09-01), None
patent: WO 03/089418 (2003-10-01), None
patent: WO 03/099793 (2003-12-01), None
patent: WO 2004/010936 (2004-02-01), None
patent: WO 2004/011446 (2004-02-01), None
patent: 2004/019869 (2004-03-01), None
patent: WO 2004/022551 (2004-03-01), None
patent: WO 2004/041266 (2004-05-01), None
patent: 2004/058174 (2004-07-01), None
patent: 2004/082601 (2004-09-01), None
patent: 2004/091604 (2004-10-01), None
patent: 2004/098498 (2004-11-01), None
patent: WO 2005/087710 (2005-09-01), None
patent: 2005/115384 (2005-12-01), None
Supplementary European Search Report issued Aug. 21, 2009 in connection with corresponding European Applicant No. 04 74 5580.
Negoro Nobuyuki
Yasuma Tsuneo
Chandrakumar Nizal S
Seaman D. Margaret
Takeda Pharmaceutical Company Limited
Wenderoth , Lind & Ponack, L.L.P.
LandOfFree
Condensed ring compound does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Condensed ring compound, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Condensed ring compound will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4206669